Kenneth Anderson

Person

Wallesley, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulating gabarap to modulate immunogenic cell death
- Patent number 12,109,266
- Issue date Oct 8, 2024
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combinations comprising a histone deacetylase inhibi...
- Patent number 12,053,468
- Issue date Aug 6, 2024
- Acetylon Pharmaceuticals, Inc.
- Steven Norman Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for modulating regulatory T cells, regulatory b cells, and...
- Patent number 12,005,073
- Issue date Jun 11, 2024
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Small molecules for inducing selective protein degradation and uses...
- Patent number 11,802,132
- Issue date Oct 31, 2023
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecules that block proteasome-associated ubiquitin receptor...
- Patent number 11,702,402
- Issue date Jul 18, 2023
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunogenic peptides specific to BCMA and TACI antigens
- Patent number 11,517,591
- Issue date Dec 6, 2022
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical combinations comprising a histone deacetylase inhibi...
- Patent number 11,497,746
- Issue date Nov 15, 2022
- Acetylon Pharmaceuticals, Inc.
- Steven Norman Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
USP7 inhibitors for treating multiple myeloma
- Patent number 11,465,983
- Issue date Oct 11, 2022
- Dana-Farber Cancer Institute, Inc.
- Sara Buhrlage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of histone deacetylase
- Patent number RE49240
- Issue date Oct 11, 2022
- The General Hospital Corporation
- Ralph Mazitschek
Information Patent Grant
Compounds for the degradation of STK4 and treatment of hematologic...
- Patent number 11,447,467
- Issue date Sep 20, 2022
- Dana-Farber Cancer Institute, Inc.
- Sara Buhrlage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical combinations comprising a histone deacetylase inhibi...
- Patent number 11,337,975
- Issue date May 24, 2022
- Acetylon Pharmaceuticals, Inc.
- Steven Norman Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
XBP1, CD138, and CS1 peptides
- Patent number 11,083,783
- Issue date Aug 10, 2021
- Dana-Farber Cancer Institute, Inc.
- Nikhil C. Munshi
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
STK4 inhibitors for treatment of hematologic malignancies
- Patent number 10,710,978
- Issue date Jul 14, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating neoplastic diseases
- Patent number 10,610,517
- Issue date Apr 7, 2020
- Celgene International II Sárl
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating multiple myeloma
- Patent number 10,302,644
- Issue date May 28, 2019
- Dana-Farber Cancer Institute, Inc.
- Teru Hideshima
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of protein degradation disorders
- Patent number 10,172,905
- Issue date Jan 8, 2019
- President and Fellows of Harvard College
- Kenneth C. Anderson
- G01 - MEASURING TESTING
Information Patent Grant
Targets in multiple myeloma and other disorders
- Patent number 10,017,767
- Issue date Jul 10, 2018
- FONDAZIONE CENTRO SAN RAFFAELE
- Giovanni Tonon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of histone deacetylase
- Patent number 9,988,343
- Issue date Jun 5, 2018
- Dana-Farber Cancer Institute, Inc.
- Ralph Mazitschek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-proliferative compounds and uses thereof
- Patent number 9,969,679
- Issue date May 15, 2018
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
XBP1, CD138, and CS1 peptides, pharmaceutical compositions that inc...
- Patent number 9,950,047
- Issue date Apr 24, 2018
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
XBP1, CD138, and CS1 peptides, pharmaceutical compositions that inc...
- Patent number 9,770,497
- Issue date Sep 26, 2017
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of protein degradation disorders
- Patent number 9,572,854
- Issue date Feb 21, 2017
- President and Fellows of Harvard College
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and agents for improving targeting of CD138 expressing tumo...
- Patent number 9,446,146
- Issue date Sep 20, 2016
- Biotest AG
- Benjamin Daelken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions, kits, and methods for identification, assessment, pre...
- Patent number 9,309,564
- Issue date Apr 12, 2016
- Dana-Farber Cancer Institute, Inc.
- Ronald A. DePinho
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inhibitors of IκB kinase for the treatment of cancer
- Patent number 9,248,124
- Issue date Feb 2, 2016
- Millennium Pharmaceuticals, Inc.
- Julian Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
XBP1, CD138, and CS1 peptides
- Patent number 9,096,681
- Issue date Aug 4, 2015
- Dana-Farber Cancer Institute, Inc.
- Nikhil C. Munshi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of protein degradation disorders
- Patent number 8,999,289
- Issue date Apr 7, 2015
- President and Fellows of Harvard College
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating neoplastic diseases
- Patent number 8,722,724
- Issue date May 13, 2014
- Triphase Research and Development I Corp.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating cancer using proteasome inhib...
- Patent number 8,685,954
- Issue date Apr 1, 2014
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating multiple myeloma using combination therapies ba...
- Patent number 8,632,772
- Issue date Jan 21, 2014
- Dana Farber Cancer Institute
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20240285740
- Publication date Aug 29, 2024
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY IMIDE DRUGS AS ZETA-CHAIN-ASSOCIATED PROTEIN KINAS...
- Publication number 20240216354
- Publication date Jul 4, 2024
- Dana-Farber Cancer Institute, Inc.
- Teru Hideshima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRPK INHIBITORS
- Publication number 20240124459
- Publication date Apr 18, 2024
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRPK INHIBITORS
- Publication number 20230271966
- Publication date Aug 31, 2023
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA
- Publication number 20230265070
- Publication date Aug 24, 2023
- Dana-Farber Cancer Institute, Inc.
- Sara Buhrlage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATME...
- Publication number 20230248769
- Publication date Aug 10, 2023
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES
- Publication number 20230210817
- Publication date Jul 6, 2023
- CELGENE INTERNATIONAL II SARL
- Kenneth C. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...
- Publication number 20230190744
- Publication date Jun 22, 2023
- ACETYLON PHARMACEUTICALS, INC.
- Steven Norman Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...
- Publication number 20220354846
- Publication date Nov 10, 2022
- ACETYLON PHARMACEUTICALS, INC.
- Steven Norman Quayle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY
- Publication number 20220218835
- Publication date Jul 14, 2022
- Medimmune, LLC
- Krista KINNEER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATING GABARAP TO MODULATE IMMUNOGENIC CELL DEATH
- Publication number 20220211848
- Publication date Jul 7, 2022
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELL RECEPTORS SPECIFIC TO B-CELL MATURATION ANTIGEN FOR TREATMEN...
- Publication number 20220118018
- Publication date Apr 21, 2022
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
XBP1, CD138, AND CS1 PEPTIDES
- Publication number 20220031821
- Publication date Feb 3, 2022
- Dana-Farber Cancer Institute, Inc.
- Nikhil C. Munshi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INC...
- Publication number 20210170004
- Publication date Jun 10, 2021
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS
- Publication number 20210128702
- Publication date May 6, 2021
- Dana-Farber Cancer Institute, Inc.
- Giada Bianchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULES THAT BLOCK PROTEASOME-ASSOCIATED UBIQUITIN RECEPTOR...
- Publication number 20210130324
- Publication date May 6, 2021
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR MODULATING REGULATORY T CELLS, REGULATORY B CELLS, AND...
- Publication number 20210113605
- Publication date Apr 22, 2021
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULES FOR INDUCING SELECTIVE PROTEIN DEGRADATION AND USES...
- Publication number 20200407371
- Publication date Dec 31, 2020
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATME...
- Publication number 20200352995
- Publication date Nov 12, 2020
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA
- Publication number 20200347031
- Publication date Nov 5, 2020
- Dana-Farber Cacer Institute, Inc.
- Sara Buhrlage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE DEGRADATION OF STK4 AND TREATMENT OF HEMATOLOGIC...
- Publication number 20200331889
- Publication date Oct 22, 2020
- Dana-Farber Cancer Institute, Inc.
- Sara Buhrlage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND IMMUNOMODULATORY...
- Publication number 20200323849
- Publication date Oct 15, 2020
- ACETYLON PHARMACEUTICALS, INC.
- Steven Norman Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES
- Publication number 20200206190
- Publication date Jul 2, 2020
- CELGENE INTERNATIONAL II SARL
- Kenneth C. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...
- Publication number 20190282573
- Publication date Sep 19, 2019
- ACETYLON PHARMACEUTICALS, INC.
- Steven Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...
- Publication number 20190282574
- Publication date Sep 19, 2019
- ACETYLON PHARMACEUTICALS, INC.
- Steven Quayle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELL CO-CULTURE SYSTEMS AND USES THEREOF
- Publication number 20190011433
- Publication date Jan 10, 2019
- Dana-Farber Cancer Institute, Inc.
- Constantine S. Mitsiades
- G01 - MEASURING TESTING
Information Patent Application
XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INC...
- Publication number 20180133297
- Publication date May 17, 2018
- Dana-Farber Cancer Institute, Inc.
- Jooeun Bae
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STK4 INHIBITORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
- Publication number 20180111916
- Publication date Apr 26, 2018
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING MULTIPLE MYELOMA
- Publication number 20170356917
- Publication date Dec 14, 2017
- Dana-Farber Cancer Institute, Inc.
- Teru Hideshima
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS OF HISTONE DEACETYLASE
- Publication number 20160272579
- Publication date Sep 22, 2016
- Dana-Farber Cancer Institute, Inc.
- Ralph Mazitschek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kenneth Anderson

Person

Patents Grantslast 30 patents

Modulating gabarap to modulate immunogenic cell death

Pharmaceutical combinations comprising a histone deacetylase inhibi...

Methods for modulating regulatory T cells, regulatory b cells, and...

Small molecules for inducing selective protein degradation and uses...

Small molecules that block proteasome-associated ubiquitin receptor...

Immunogenic peptides specific to BCMA and TACI antigens

Pharmaceutical combinations comprising a histone deacetylase inhibi...

USP7 inhibitors for treating multiple myeloma

Inhibitors of histone deacetylase

Compounds for the degradation of STK4 and treatment of hematologic...

Pharmaceutical combinations comprising a histone deacetylase inhibi...

XBP1, CD138, and CS1 peptides

STK4 inhibitors for treatment of hematologic malignancies

Compositions and methods for treating neoplastic diseases

Compositions and methods for treating multiple myeloma

Treatment of protein degradation disorders

Targets in multiple myeloma and other disorders

Inhibitors of histone deacetylase

Anti-proliferative compounds and uses thereof

XBP1, CD138, and CS1 peptides, pharmaceutical compositions that inc...

XBP1, CD138, and CS1 peptides, pharmaceutical compositions that inc...

Treatment of protein degradation disorders

Methods and agents for improving targeting of CD138 expressing tumo...

Compositions, kits, and methods for identification, assessment, pre...

Use of inhibitors of IκB kinase for the treatment of cancer

XBP1, CD138, and CS1 peptides

Treatment of protein degradation disorders

Compositions and methods for treating neoplastic diseases

Methods and compositions for treating cancer using proteasome inhib...

Methods of treating multiple myeloma using combination therapies ba...

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TREATING CANCER

IMMUNOMODULATORY IMIDE DRUGS AS ZETA-CHAIN-ASSOCIATED PROTEIN KINAS...

PRPK INHIBITORS

PRPK INHIBITORS

NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA

IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATME...

COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...

COMBINATION THERAPY

MODULATING GABARAP TO MODULATE IMMUNOGENIC CELL DEATH

T CELL RECEPTORS SPECIFIC TO B-CELL MATURATION ANTIGEN FOR TREATMEN...

XBP1, CD138, AND CS1 PEPTIDES

XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INC...

USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS

SMALL MOLECULES THAT BLOCK PROTEASOME-ASSOCIATED UBIQUITIN RECEPTOR...

METHODS FOR MODULATING REGULATORY T CELLS, REGULATORY B CELLS, AND...

SMALL MOLECULES FOR INDUCING SELECTIVE PROTEIN DEGRADATION AND USES...

IMMUNOGENIC PEPTIDES SPECIFIC TO BCMA AND TACI ANTIGENS FOR TREATME...

NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA

COMPOUNDS FOR THE DEGRADATION OF STK4 AND TREATMENT OF HEMATOLOGIC...

COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND IMMUNOMODULATORY...

COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBI...

CELL CO-CULTURE SYSTEMS AND USES THEREOF

XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INC...

STK4 INHIBITORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE MYELOMA

INHIBITORS OF HISTONE DEACETYLASE